Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.

Journal of child and adolescent psychopharmacology - 1 Oct 2015

Fang Yantong, Ji Ning, Cao Qingjiu, Su Yi, Chen Min, Wang Yufeng, Yang Li

Abstract excerpt

OBJECTIVE: Atomoxetine is the most widely used nonstimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD). It selectively acts on the norepinephrine (NE) system. Dopamine beta hydroxylase (DBH) regulates the synthesis of NE. This study aimed to investigate whether variants in the DBH gene have an effect on the differential response to atomoxetine. METHODS: Children and adolescents with ADHD...

Topics

Join the communities discussing this publication.

Attention Deficit Disorder with Hyperactivity
Child
Dopamine beta-Hydroxylase
Genotype
Haplotypes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Linkage Disequilibrium

Polymorphism, Single Nucleotide

Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 26447643
DOI: 10.1089/cap.2014.0178
PMCID: PMC4615817

Genes

DBH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variants of Dopamine Beta Hydroxylase Gene Moderate Atomoxetine Response in Children with Attention-Deficit/Hyperactivity Disorder.PMID 26447643Read ↗

Adrenergic neurotransmitter system transporter and receptor genes associated with atomoxetine response in attention-deficit hyperactivity disorder children.Semantic proximity Read ↗

A haplotype of the norepinephrine transporter (Net) gene Slc6a2 is associated with clinical response to atomoxetine in attention-deficit hyperactivity disorder (ADHD).Semantic proximity Read ↗

Role of the norepinephrine transporter polymorphisms in atomoxetine treatment: From response to side effects in children with ADHD.Semantic proximity Read ↗

Personalizing Atomoxetine Dosing in Children with ADHD: What Can We Learn from Current Supporting EvidenceSemantic proximity Read ↗

Identification and functional characterisation of a novel dopamine beta hydroxylase gene variant associated with attention deficit hyperactivity disorder.Semantic proximity Read ↗

Pharmacogenetic Approach for a Better Drug Treatment in ChildrenSemantic proximity Read ↗

Attention-deficit/hyperactivity disorder pharmacogenomics.Semantic proximity Read ↗

Evaluation of SLCA62 and CYP2D6 Polymorphisms’ Effects on Atomoxetine Treatment in Attention Deficit and Hyperactivity DisorderSemantic proximity Read ↗

Attention deficit hyperactivity disorder.Semantic proximity Read ↗

Candidate Gene Expression Investigation in Children With Attention Deficit Hyperactivity DisorderSemantic proximity Read ↗

Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.Semantic proximity Read ↗

Lack of significant association between -1021C-->T polymorphism in the dopamine beta hydroxylase gene and attention deficit hyperactivity disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.